Brief: Ajanta Pharma's Dahej facility does not get form 483 after FDA inspection
April 10 (Reuters) - Ajanta Pharma Ltd AJPH.NS
* Ajanta Pharma Ltd says co's Dahej facility was inspected
by FDA from April 3-7, 2017; no form 483 was issued
Source text:
[This is to inform you that Company's formulation facility at
Dahej was
inspected by US FDA from 3rd to 7th April, 2017. At the end of
the
inspection, no Form 483 was issued to the Company]
Further company coverage: AJPH.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility